We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Reports of positive early results from a COVID-19 trial of Gilead’s antiviral drug remdesivir in Chicago are premature, according to the University of Chicago Medicine and Biological Sciences. Read More
As the desperate search for a COVID-19 treatment continues, two phase 3 trials in China of Gilead’s remdesivir as a treatment have been suspended due to the lack of eligible patients. Meanwhile, multiple trials of the drug in the U.S. and Europe are going forward. Read More
The World Health Organization (WHO) has reported that there are 70 novel coronavirus vaccines in development around the globe with three already in human trials. Read More